Elanco Animal Health Files 2024 10-K
Ticker: ELAN · Form: 10-K · Filed: 2025-02-25T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, animal-health, pharmaceuticals
Related Tickers: ELAN
TL;DR
Elanco Animal Health filed its 2024 10-K, detailing FY performance and risks.
AI Summary
Elanco Animal Health Inc. filed its 2024 10-K on February 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in Greenfield, Indiana, operates in the pharmaceutical preparations sector. This filing provides a comprehensive overview of Elanco's financial performance, business operations, and risk factors for the year.
Why It Matters
This 10-K filing provides investors and stakeholders with a detailed look at Elanco's financial health and strategic direction for the past fiscal year, influencing investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Elanco faces inherent risks related to product development, regulatory approvals, competition, and market demand for animal health products.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 2025-02-25 — Filing Date (The date Elanco Animal Health submitted its 10-K to the SEC.)
Key Players & Entities
- Elanco Animal Health Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-25 (date) — Filing date
- Greenfield, IN (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What was Elanco Animal Health's total revenue for the fiscal year ended December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ended December 31, 2024. A full review of the 10-K document would be required to find this information.
What are the primary business segments of Elanco Animal Health?
The provided text does not detail Elanco's business segments. This information would be found within the full 10-K filing.
What is Elanco Animal Health's stock ticker symbol?
The provided text does not explicitly state Elanco Animal Health's stock ticker symbol. However, the filing is for 'elan-20241231.htm', suggesting 'ELAN' might be the ticker.
When did Elanco Animal Health's fiscal year 2023 end?
Elanco Animal Health's fiscal year 2023 ended on December 31, 2023, as indicated by the date range '2023-01-01 2023-12-31'.
What is the company's primary industry classification?
Elanco Animal Health Inc. is classified under Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
0001739104-25-000014.txt : 20250225 0001739104-25-000014.hdr.sgml : 20250225 20250225091237 ACCESSION NUMBER: 0001739104-25-000014 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 143 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250225 DATE AS OF CHANGE: 20250225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825497352 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 25659679 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 10-K 1 elan-20241231.htm 10-K FOR THE YEAR ENDED DECEMBER 31, 2024 elan-20241231 FALSE false 2024 FY 0001739104 http://fasb.org/us-gaap/2024#RestructuringCostsAndAssetImpairmentCharges http://fasb.org/us-gaap/2024#RestructuringCostsAndAssetImpairmentCharges http://fasb.org/us-gaap/2024#RestructuringCostsAndAssetImpairmentCharges http://fasb.org/us-gaap/2024#RestructuringCostsAndAssetImpairmentCharges http://fasb.org/us-gaap/2024#RestructuringCostsAndAssetImpairmentCharges http://fasb.org/us-gaap/2024#RestructuringCostsAndAssetImpairmentCharges P1Y http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent 1 1 iso4217:USD xbrli:shares iso4217:USD xbrli:shares elan:country xbrli:pure elan:employee elan:covenant iso4217:CHF elan:executive elan:claim elan:segment 0001739104 2024-01-01 2024-12-31 0001739104 2024-06-30 0001739104 2025-02-20 0001739104 2023-01-01 2023-12-31 0001739104 2022-01-01 2022-12-31 0001739104 2024-12-31 0001739104 2023-12-31 0001739104 us-gaap:CommonStockMember 2021-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001739104 us-gaap:RetainedEarningsMember 2021-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001739104 2021-12-31 0001739104 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001739104 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001739104 us-gaap:CommonStockMember 2022-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001739104 us-gaap:RetainedEarningsMember 2022-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001739104 2022-12-31 0001739104 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001739104 us-gaap:CommonStockMember 2023-01-01 2023-12-31